Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Israel launches airstrikes on south Lebanon
Death toll of Bosnian retirement home fire rises to 12
Voting ends in first phase of election in India's Bihar
Britain's Prince William calls for optimism on environment at EarthShot Prize event
Afghanistan and Pakistan return to Istanbul for more peace talks